Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion.

Literature DB >> 33232876

On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion.

Matthias M Herth¹, Simon Ametamey², Dmitrii Antuganov³, Andreas Bauman⁴, Mathias Berndt⁵, Allen F Brooks⁶, Guy Bormans⁷, Yearn Seong Choe⁸, Nic Gillings⁹, Urs O Häfeli¹⁰, Michelle L James¹¹, Klaus Kopka¹², Vasko Kramer¹³, Raisa Krasikova¹⁴, Jacob Madsen⁹, Linjing Mu², Bernd Neumaier¹⁵, Markus Piel¹⁶, Frank Rösch¹⁶, Tobias Ross¹⁷, Roger Schibli², Peter J H Scott⁶, Vladimir Shalgunov¹⁸, Neil Vasdev¹⁹, Wolfgang Wadsak²⁰, Brian M Zeglis²¹.

Abstract

Radiochemical conversion is an important term to be included in the "Consensus nomenclature rules for radiopharmaceutical chemistry". Radiochemical conversion should be used to define reaction efficiency by measuring the transformation of components in a crude reaction mixture at a given time, whereas radiochemical yield is better suited to define the efficiency of an entire reaction process including, for example, separation, isolation, filtration, and formulation.

Keywords: Consensus guidelines; Nomenclature; Nuclear chemistry; Radiochemical conversion; Radiochemical yield; Radiochemistry; Radiopharmaceutical sciences; Terminology

Year: 2020 PMID： 33232876 DOI： 10.1016/j.nucmedbio.2020.11.003

Source DB: PubMed Journal: Nucl Med Biol ISSN： 0969-8051 Impact factor: 2.408

Keyword Cloud
Cited

6 in total

1. Optimization of Direct Aromatic ¹⁸F-Labeling of Tetrazines.

Authors: Ida Vang Andersen; Rocío García-Vázquez; Umberto Maria Battisti; Matthias M Herth
Journal: Molecules Date: 2022-06-22 Impact factor: 4.927

Review 2. Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging.

Authors: Rocío García-Vázquez; Umberto Maria Battisti; Matthias M Herth
Journal: Pharmaceuticals (Basel) Date: 2022-05-30

3. Insights into Elution of Anion Exchange Cartridges: Opening the Path toward Aliphatic ¹⁸F-Radiolabeling of Base-Sensitive Tracers.

Authors: Klas Bratteby; Vladimir Shalgunov; Umberto Maria Battisti; Ida Nyman Petersen; Sara Lopes van den Broek; Tomas Ohlsson; Nic Gillings; Maria Erlandsson; Matthias M Herth
Journal: ACS Pharmacol Transl Sci Date: 2021-08-12

4. Development of ¹⁸F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging.

Authors: Rocío García-Vázquez; Jesper Tranekjær Jørgensen; Klas Erik Bratteby; Vladimir Shalgunov; Lars Hvass; Matthias M Herth; Andreas Kjær; Umberto Maria Battisti
Journal: Pharmaceuticals (Basel) Date: 2022-02-18

5. Fully Automated GMP-Compliant Synthesis of [¹⁸F]FE-PE2I.

Authors: Klas Bratteby; Charlotte Lund Denholt; Szabolcs Lehel; Ida Nymann Petersen; Jacob Madsen; Maria Erlandsson; Tomas Ohlsson; Matthias Manfred Herth; Nic Gillings
Journal: Pharmaceuticals (Basel) Date: 2021-06-22

6. Optimisation of the Synthesis and Cell Labelling Conditions for [⁸⁹Zr]Zr-oxine and [⁸⁹Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications.

Authors: Ida Friberger; Emma Jussing; Jinming Han; Jeroen A C M Goos; Jonathan Siikanen; Helen Kaipe; Mélanie Lambert; Robert A Harris; Erik Samén; Mattias Carlsten; Staffan Holmin; Thuy A Tran
Journal: Mol Imaging Biol Date: 2021-07-06 Impact factor: 3.488

6 in total

On the consensus nomenclature rules for radiopharmaceutical chemistry - Reconsideration of radiochemical conversion.

1. Optimization of Direct Aromatic 18F-Labeling of Tetrazines.

Review 2. Recent Advances in the Development of Tetrazine Ligation Tools for Pretargeted Nuclear Imaging.

3. Insights into Elution of Anion Exchange Cartridges: Opening the Path toward Aliphatic 18F-Radiolabeling of Base-Sensitive Tracers.

4. Development of 18F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging.

5. Fully Automated GMP-Compliant Synthesis of [18F]FE-PE2I.

6. Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications.

1. Optimization of Direct Aromatic ¹⁸F-Labeling of Tetrazines.

3. Insights into Elution of Anion Exchange Cartridges: Opening the Path toward Aliphatic ¹⁸F-Radiolabeling of Base-Sensitive Tracers.

4. Development of ¹⁸F-Labeled Bispyridyl Tetrazines for In Vivo Pretargeted PET Imaging.

5. Fully Automated GMP-Compliant Synthesis of [¹⁸F]FE-PE2I.

6. Optimisation of the Synthesis and Cell Labelling Conditions for [⁸⁹Zr]Zr-oxine and [⁸⁹Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications.